Actos Buyers Fight Takeda Appeal Bid In Drug Delay Case
End payors and direct buyers of the diabetes drug Actos have urged a New York federal judge to nix Takeda's bid to immediately appeal her decision preserving some class action claims against the...To view the full article, register now.
Already a subscriber? Click here to view full article